SKI Market

Indian Indices

Nifty

25,509.70 -87.95
(-0.34%)

Sensex

83,311.01 -148.14
( -0.18%)

Bank Nifty

57,554.25 -272.80
( -0.47%)

Nifty IT

35,337.60 63.05
( 0.18%)

Global Indices

Nasdaq

46,931.02 -400.98
(-0.85%)

Dow Jones

6,741.06 -76.23
(-1.12%)

Hang Seng

50,848.14 635.87
(1.27%)

Nikkei 225

9,736.38 -40.70
(-0.42%)

Forex

USD-INR

88.68 -0.07
(-0.08%)

EUR-INR

101.96 -0.30
(-0.29%)

GBP-INR

115.92 -0.66
(-0.56%)

JPY-INR

0.58 0.00
(0.22%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

365.9334533

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

33.07

66829.23

EPS(TTM)

Face Value()

Div & Yield %

34.49

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	10933.30	10645.64	12792.28	11287.14	15823.68	13370.77
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	10933.30	10645.64	12792.28	11287.14	15823.68	13370.77
Other Income	328.12	670.10	433.76	670.99	589.86	388.79
Stock Adjustments	67.66	116.23	466.00	-45.51	-2.99	238.67
Total Income	11329.08	11431.97	13692.04	11912.62	16410.55	13998.23
EXPENDITURE :
Raw Materials	5675.34	5964.48	7336.92	5800.74	7241.83	6819.85
Power & Fuel Cost	185.59	191.58	613.92	477.99	512.34	526.31
Employee Cost	1063.07	980.56	1641.88	1600.04	1735.42	1577.14
Other Manufacturing Expenses	426.63	414.51	650.91	705.68	925.86	814.44
Selling & Administrative Expenses	960.27	822.21	1089.33	1009.36	1069.84	938.36
Miscellaneous Expenses	132.49	164.49	194.40	249.13	215.57	235.47
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	8443.39	8537.83	11527.36	9842.94	11700.86	10911.57
Operating Profit	2885.69	2894.14	2164.68	2069.68	4709.69	3086.66
Interest	230.04	182.60	114.98	16.94	28.68	243.28
Gross Profit	2655.65	2711.54	2049.70	2052.74	4681.01	2843.38
Depreciation	297.20	254.58	435.35	415.26	488.00	473.33
Profit Before Tax	2358.45	2456.96	1614.35	1637.48	4193.01	2370.05
Tax	627.37	598.08	407.02	379.70	1043.34	492.28
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-15.71	-95.26	-23.08	-196.93	36.76	0.89
Reported Net Profit	1746.79	1954.14	1230.41	1454.71	3112.91	1876.88
Extraordinary Items	5.48	1.17	9.98	-81.27	-0.13	-1.90
Adjusted Net Profit	1741.31	1952.97	1220.43	1535.98	3113.04	1878.78
Adjustment below Net Profit	-5.26	-1.69	5.87	1.69	-6.42	-44.88
P & L Balance brought forward	18348.87	16660.08	15864.14	14671.41	11799.30	10143.08
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	263.66	439.45	263.67	234.38	175.78
P & L Balance carried down	20090.40	18348.87	16660.97	15864.14	14671.41	11799.30
Dividend	0.00	263.66	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	450.00	750.00	900.00	400.00	300.00
Dividend Per Share(Rs)	0.00	4.50	7.50	9.00	4.00	3.00
Earnings Per Share-Unit Curr	30.08	33.35	21.00	24.83	53.13	32.03
Earnings Per Share(Adj)-Unit Curr	30.08	33.35	21.00	24.83	53.13	32.03
Book Value-Unit Curr	353.55	336.62	305.75	292.15	271.80	222.78
Book Value(Adj)-Unit Curr	353.55	336.62	305.75	292.15	271.80	222.78

25,509.70 -87.95 (-0.34%)

83,311.01 -148.14 ( -0.18%)

57,554.25 -272.80 ( -0.47%)

35,337.60 63.05 ( 0.18%)

46,931.02 -400.98 (-0.85%)

6,741.06 -76.23 (-1.12%)

50,848.14 635.87 (1.27%)

9,736.38 -40.70 (-0.42%)

88.68 -0.07 (-0.08%)

101.96 -0.30 (-0.29%)

115.92 -0.66 (-0.56%)

0.58 0.00 (0.22%)